Citi Starts PTC Therapeutics At Buy, Sees One Of Year's Biggest Binary Events Coming

By: via Benzinga
Shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) have declined more than 36 percent year-to-date. Citi’s Joel Beatty ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.